StockNoteStockNote
Cuu Long Pharmaceutical Joint Stock Company (DCL) was established in 1997. In 2004, the company switched to a shareholding model. The company specializes in manufacturing, trading and importing and exporting pharmaceuticals, capsules, all kinds of medical tools and equipment for the pharmaceutical industry and medical industry. DCL has 5 factories in operation, including 4 factories meeting GMP-WHO standards. In addition to the domestic market, the company's products are also exported to Cambodia, Laos, Myanmar and Nigeria. DCL has been listed on the Ho Chi Minh City Stock Exchange (hose) since 2008.
DCL currently has a market capitalization of roughly VND 2.849 billion, placing it in the mid-cap group on the Vietnamese stock market. Its current P/E of 139,6x is 199% above its own 8-year average (46,6x), suggesting the stock is trading richer than its historical norm. P/B stands at 1,9x, 10% above its multi-year average of 1,7x. Return on equity (ROE) is at -0,1%, down from 1,3% the year before. Its debt-to-equity ratio of 0,5x is low, reflecting a conservative capital structure. In 2025, revenue grew 1% year-on-year while after-tax profit fell 63%.
This note is generated automatically from the stock's real financial data, for reference only — not investment advice.
Unit: VND billion. Growth (%) vs. previous period.
Unit: VND billion. Year-end values; current year uses latest session.
Unit: x. Financial debt over shareholders' equity.
Data aggregated from cafef.vn and VNDirect, for reference only, not investment advice.